Ftse Mib
33.746,66
-1,60%
DAX
17.932,17
-1,10%
S&P 500
5.018,39
-0,34%
NASDAQ Composite
15.605,48
-0,33%
Bitcoin
57.867,20
-4,51%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Regno Unito LSE Roquefort Therapeutics Plc (ROQ) Roquefort Therapeutics Plc (ROQ) Notizie

Roquefort Therapeutics Plc

ROQ
4,40
0,00 (0,00%)
01 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: Londra
Tipo: Azione Ordinaria
Valuta: GBX

Ultime notizie

Data Ora Fonte Titolo
26/4/202421:59ALNCNewsEARNINGS AND TRADING: Aura confident in Tiris; Cindrigo..
26/4/202408:00LSEG_RNSRoquefort Therapeutics PLC Annual Report & Financial..
05/4/202413:32ALNCNewsIN BRIEF: Roquefort cancels fundraise after "unusual" stock..
05/4/202408:00LSEG_RNSRoquefort Therapeutics PLC Response to Share Price Movement
11/3/202412:12ALNCNewsRoquefort celebrates "significant milestones" in cancer..
11/3/202408:00LSEG_RNSRoquefort Therapeutics PLC Positive Results: Midkine mRNA..
06/2/202417:50ALNCNewsIN BRIEF: Roquefort hails further MK studies, licence talks..
06/2/202408:00LSEG_RNSRoquefort Therapeutics PLC Operations Update
24/11/202308:00UKREGRoquefort Therapeutics PLC Change of Auditor
06/11/202313:01ALNCNewsRoquefort Therapeutics MK cell programme shows positive..
06/11/202308:00UKREGRoquefort Therapeutics PLC Significant Mesodermal Killer..
27/9/202316:43ALNCNewsEARNINGS: Biome loss widens; Amicorp focused on growth..
27/9/202308:00UKREGRoquefort Therapeutics PLC Interim Results to 30 June 2023
22/9/202312:42RNSNONRoquefort Therapeutics PLC Investor Presentation via..
14/8/202312:07ALNCNewsRoquefort files patent application for mRNA and RNA..
14/8/202308:00UKREGRoquefort Therapeutics PLC Expansion of Patent Portfolio
07/8/202312:04ALNCNewsIN BRIEF: Roquefort announces new sirNA sequences and patent..
07/8/202308:00UKREGRoquefort Therapeutics PLC Development of New Novel siRNA..
02/8/202308:00UKREGRoquefort Therapeutics PLC Director/PDMR Shareholding
12/7/202311:27UKREGRoquefort Therapeutics PLC Director/PDMR Shareholding
29/6/202319:51ALNCNewsTRADING UPDATES: Anpario trading in line, Likewise Group..
29/6/202311:05UKREGRoquefort Therapeutics PLC Results of AGM
29/6/202308:00UKREGRoquefort Therapeutics PLC AGM Statement
27/6/202308:00RNSNONRoquefort Therapeutics PLC Investor Presentation via..
26/6/202317:34UKREGRoquefort Therapeutics PLC Director/PDMR Shareholding
26/6/202311:36UKREGRoquefort Therapeutics PLC Director/PDMR Shareholding
26/6/202311:00UKREGRoquefort Therapeutics PLC Director/PDMR Shareholding
22/6/202321:34ALNCNewsTRADING UPDATES: Plant Health Care announces GBP2.8 million..
22/6/202308:00UKREGRoquefort Therapeutics PLC RNA Medicine Shows In Vitro..
19/6/202313:28ALNCNewsRoquefort Therapeutics celebrates cancer antibody trial..
19/6/202308:00UKREGRoquefort Therapeutics PLC Antibody Program Results & Orphan..
13/6/202312:52ALNCNewsIN BRIEF: Roquefort says anti-cancer mRNA study shows..
13/6/202308:00UKREGRoquefort Therapeutics PLC Anti-Cancer MDK mRNA - Positive..
07/6/202315:41ALNCNewsIN BRIEF: Roquefort Therapeutics suspension on shares lifted
07/6/202311:11UKREGRoquefort Therapeutics PLC Restoration of Trading
06/6/202308:00UKREGRoquefort Therapeutics PLC Notice of Annual General Meeting
05/6/202312:50ALNCNewsRoquefort Therapeutics loss widens as administrative costs..
05/6/202308:00UKREGRoquefort Therapeutics PLC Annual Report & Financial..
02/5/202308:56UKREGRoquefort Therapeutics PLC Suspension of Trading Pending..
02/5/202308:30UKREGOfficial List Suspension - Roquefort Therapeutics plc
Apertura: 4,40 Min: 4,40 Max: 4,40
Chiusura: 4,40

La tua Cronologia

LSE
ROQ
Roquefort Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network